Apterna is a pre-clinical biotechnology company developing chemically synthesized RNA aptamers. It focuses on internalizing RNA aptamers that enable targeted delivery of various payloads, including RNA, toxins, enzymes, chemotherapy agents, photodynamic molecules, radionuclides, and nanocarriers.